Page 4 - Metropolis Healthcare

Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

Since, 2002, Metropolis has used its brand strength to establish large networks through acquisitions in Chennai, Rajkot, Surat, Bangalore, Pune as well as outside India

Metropolis Healthcare Q2 revenue up 15% to Rs 223 crore, PAT rises 43.7%

The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7% from Rs 30 crore in Q2 FY19

Serial entrepreneur G S K Velu to ramp up diagnostics biz in west and south

Move follows expiry of restrictive clauses inserted at the time he sold his stake in Metropolis Healthcare to Carlyle Group

Metropolis Healthcare shares gain 9% over issue price on debut

On a price-to-earnings (P/E) valuation basis, analysts said Metropolis is cheaper than Dr Lal Pathlabs

Metropolis Healthcare open to acquisitions; IPO to hit Street on Wednesday

Sushil Shah, chairman of Metropolis Healthcare, said if a good acquisition opportunity came up, they were open to evaluate it

Diagnostics firm Metropolis Healthcare files IPO draft papers with Sebi

Shares of the company are proposed to be listed on BSE and NSE

Metropolis' Ameera Shah resists listing

Rivals Dr Lal's and Thyrocare command valuations over 50 times earnings

Metropolis Healthcare eyes Asia markets for growth

The firm, which had exited South Africa in August, now is quite bullish about Africa as a market